Skip to main content
All lobbying filings

BROYDRICK & ASSOCIATES

Lobbying for TONIX PHARMACEUTICALS · Pharmaceutical development and manufacturing.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate · $20,000.00 income · posted Jul 17, 2025

Official filing document

 Lobbying activity 1
Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem